Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study to Compare OASIS Extracellular Matrix to Standard Wound Care for Treatment of Donor Site Wounds

NCT04079348 is registered in ClinicalTrials.gov with Cook Biotech Incorporated as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04079348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study to Compare OASIS Extracellular Matrix to Standard Wound Care for Treatment of Donor Site Wounds
Lead sponsor
Cook Biotech Incorporated
Phase
Not applicable
Overall status
Recruiting
Start date
November 1, 2020
Completion date
December 31, 2025
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

surgical wound, wound, wound heal, wounds and injuries